title: New agents in cancer clinical trials.
authors: Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts 02139, USA.
authors: J
authors: J
authors: Adams
authors: P J
authors: PJ
authors: Elliott
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D016227:Benzoquinones; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D004149:Dioxoles / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D000068877:Imatinib Mesylate; D007546:Isoquinolines / Q000627:therapeutic use; D047029:Lactams, Macrocyclic; D009369:Neoplasms / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D017828:Rifabutin / Q000031:analogs & derivatives / Q000627:therapeutic use; D013267:Stilbenes / Q000627:therapeutic use; D013763:Tetrahydrofolates / Q000627:therapeutic use; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin; D000077337:Vorinostat
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D016227:Benzoquinones; D001897:Boronic Acids; D004149:Dioxoles; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D007546:Isoquinolines; D047029:Lactams, Macrocyclic; D010879:Piperazines; D011719:Pyrazines; D011743:Pyrimidines; D013267:Stilbenes; D013763:Tetrahydrofolates; D044005:Tetrahydroisoquinolines; D017828:Rifabutin; C112765:tanespimycin; D000077337:Vorinostat; D000069286:Bortezomib; C045894:lometrexol; D000068877:Imatinib Mesylate; C058728:fosbretabulin; D000077606:Trabectedin